Nuvation Bio Ratios (2023-2025) | NUVB

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 6.13%-108.39%26.18%32.10%46.70%74.47%
EBT Margin -32,229.41%-5,668.50%-865.79%-1,726.20%-1,220.92%-425.24%
EBIT Margin -32,779.44%-6,616.37%-944.53%-1,913.23%-1,315.73%-430.14%
EBITDA Margin -32,236.17%-5,304.40%-879.93%-1,727.11%-1,238.94%-423.81%
Operating Margin -32,779.44%-6,616.37%-944.53%-1,913.23%-1,315.73%-430.14%
Net Margin -32,229.41%-5,668.50%-865.79%-1,726.20%-1,220.92%-425.24%
FCF Margin -2,600.98%-4,296.15%-810.52%-1,384.53%-1,000.60%-462.21%
Efficiency
Inventory Average 0.28M3.13M
Assets Average 649.23M636.14M626.18M617.30M603.96M583.19M556.10M516.56M569.86M624.39M
Equity Average 632.85M618.11M608.36M599.58M425.62M379.95M483.25M441.62M396.18M349.39M
Invested Capital 641.07M624.63M611.59M605.12M594.04M268.83M511.14M470.07M425.14M378.49M331.50M
Asset Utilization Ratio 0.000.000.010.020.030.04
Leverage & Solvency
Interest Coverage Ratio -0.00M-400.84-606.09-0.00M-151.04-11.02
Debt to Equity 0.050.020.010.010.140.16
Debt Ratio 0.020.010.010.010.080.09
Equity Ratio 0.980.970.970.970.970.430.880.860.850.580.54
Times Interest Earned -0.00M-400.84-606.09-0.00M-151.04-11.02
Valuation
Enterprise Value -646.61M-630.90M-619.34M-611.21M-596.98M-577.17M-549.13M-502.69M-461.68M-607.72M-549.04M
Return Ratios
Return on Sales -322.29%-56.69%-8.66%-17.26%-12.21%-4.25%
Return on Capital Employed -0.16%-0.16%-0.97%-1.07%-1.19%-1.36%-0.45%-0.42%
Return on Assets -0.12%-0.11%-0.85%-0.91%-1.02%-1.17%-0.36%-0.35%
Return on Equity -0.12%-0.11%-1.20%-1.40%-1.18%-1.37%-0.51%-0.62%